Locations:
Search
Percutaneous stabilization can increase mobility without disrupting cancer treatment
International study supports change in clinical care in post-neoadjuvant setting
Early detection, prognostication and intervention may improve outcomes
Preliminary results suggest combination therapy with lisaftoclax improves survival with few adverse events in patients with AL amyloidosis and relapsed/refractory multiple myeloma
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Risk is not trivial; finding may assist in informed decision making
Evidence-based recommendations for balancing cancer control with quality of life
New research demonstrates that cfDNA methylation patterns may noninvasively identify tumor hypoxia in head and neck squamous cell carcinoma
Program reduces major contour changes and variations in organ-at-risk dosing across health system
No significant differences seen in breast volume loss between whole and partial breast treatment approaches
Despite wide variations in contours, researchers find AI and physician methods yield equivalent results.
Advertisement
Advertisement